The POBIG (Pre-Operative Brian Irradiation in Glioblastoma) study, which is trialling radiotherapy before brain surgery, could potentially be a game-changer for the treatment of the most common type of brain tumour.
The POBIG (Pre-Operative Brian Irradiation in Glioblastoma) study, which is trialling radiotherapy before brain surgery, could potentially be a game-changer for the treatment of the most common type of brain tumour.
The Stroke-IMPaCT team are organising an event called Brain Health Day! Researchers who work on the Stroke-IMPaCT Project will be in attendance, as well as other scientists from the Geoffrey Jefferson Brain Research Centre doing research into other conditions such as Brain Tumours.
A major research project to help improve treatments for Parkinson’s disease will take place at Manchester Metropolitan University, Northern Care Alliance NHS Foundation Trust (NCA) and the Walton Centre (NHS Trust Centre for Neurology and Neurosurgery) in Liverpool. The project will be led by, investigator in our centre’s Parkinson’s theme, Professor Nicola Ray, Manchester Metropolitan’s Department of Psychology and her Co-Investigators at the NCA, Walton Centre and The University of Manchester. Professor Ray developed the ideas for the project from work she and the team have undertaken with funding from Health Innovation Manchester.
Funding has been awarded through the dual-award PhD programme between the University of Melbourne and University of Manchester. The dual-award scheme brings together research teams between the two institutions with a PhD student assigned to each. This is a highly competitive scheme with just six dual awards (twelve students) made across both Universities in all disciplines. For our researchers to secure two of these awards is therefore a fantastic achievement.
The Association of British Neurologists’ Movement Disorders Special Interest Group meeting will come to Manchester for the first time in January 2023.
Post-stroke cognitive decline is one of the most distressing complications in stroke survivors, occurring in up to a third of those affected by stroke within five years. Laura Parkes, Craig Smith and Stuart Allan have been awarded funding to track changes in the brain over months and years in people who have suffered a stroke. The Imaging Hub will be based in Manchester, with $780k funding for research scans and an imaging scientist to work with Dr Parkes and her team.
The Research Excellence Framework is the system for assessing the quality of research in UK higher education institutions, including research impact, the research environment, research publications and other outputs. One of the high-scoring impact case studies was led by Prof Audrey Bowen, who leads the Centre’s research theme – Rehabilitation and Living with Disability.
We are delighted to announce a new theme has joined our centre.
Leading brain cancer expert, Professor Petra Hamerlik has been appointed the inaugural Brain Tumour Charity Neuro-oncology Chair in Manchester.
A novel clot-busting drug is able to effectively restore blood flow in the brains of mice, opening the door for a safer and more effective stroke treatment.
Recent Comments